Global Congenital Heart Disease Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Congenital Heart Disease Market was valued at $14.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.2% CAGR, to an estimated market size of $21.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global Congenital Heart Disease (CHD) market encompasses the comprehensive ecosystem for the diagnosis, treatment, and management of structural heart abnormalities present at birth. This includes medical devices (such as occluders, stents, and transcatheter valves), diagnostic imaging (echocardiography, MRI, CT), surgical interventions, and pharmaceutical therapies tailored for both pediatric and adult patients with congenital defects.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Congenital Heart Disease Market in the period 2025-30:
- Rapid shift toward minimally invasive transcatheter interventions, such as non-surgical heart valves, to reduce recovery time and surgical trauma.
- Integration of Artificial Intelligence (AI) and machine learning in prenatal diagnostics to enhance the accuracy of fetal heart ultrasound evaluations.
- Rising global prevalence of CHD driven by increased risk factors such as maternal diabetes and improved early-stage screening protocols.
- Expansion of the adult CHD population due to higher survival rates, creating a growing market for long-term clinical management and specialized adult care.
- Development of pediatric-specific innovations, including growth stents and miniature pacemakers designed to accommodate a child's physical development.
- Advancements in cardiac tissue engineering and 3D bioprinting for the creation of regenerative heart valves and vascular grafts.
- Increased government investment in pediatric cardiac infrastructure and newborn screening programs, particularly in emerging Asia-Pacific economies.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Segments
- Heart Valve Defects
- Heart Wall Defects
- Blood Vessel Defects
- Others